CAMBRIDGE, UK – Morpho (Safran), through its subsidiary Morpho Detection, today announced a contract with UK Airport Operator Manchester Airports Group Plc (M.A.G.) for 44 Itemiser® 4DXexplosives trace detectors (ETD). Using a non-radioactive ionization source and simultaneous, dual-mode detection, Itemiser® 4DX can detect a broad range of current market threat explosives and narcotics without the […]
WILMINGTON, Mass. — Implant Sciences Corporation(OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, announced today the appointment of Robert Liscouski to the position of President. Mr. Liscouski, formerly Executive Vice President, will continue to serve on the company’s Board of Directors. Dr. Bill McGann […]
WILMINGTON, Mass. — Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has sold 22 of its QS-B220 desktop trace detectors to international airports in Austria, continuing its sales success in the European aviation market. With this contract […]
WILMINGTON, Mass. — Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that its QS-B220 desktop explosives trace detector has been selected in a Romanian airport tender. With this sale, Implant Sciences’ trace detectors have been sold to customers in […]
WILMINGTON, Mass. — Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced an important sale of 50 of its QS-B220 desktop explosives trace detectors to several international airports in Germany. “Among the German airports in this sale was an airport […]
WILMINGTON, Mass. — Implant Sciences Corporation(OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced the award of its 19th patent. Titled “Trace Chemical Particle Release Nozzle” (Patent No. 9,067,219), this patent enhances Implant Sciences’ non-contact sampling capability to allow for its integration and use […]
ROCKVILLE, Md. – Lockheed Martin (NYSE: LMT) today announced the formation of a new healthcare technology alliance, combining the expertise of leading health IT providers, medical technology companies, and academic institutions to advance public health. The Lockheed Martin Healthcare Technology Alliance’s founding members include: Cisco, Cloudera, Illumina, Intel and Montgomery College. “Federal health IT is […]
WILMINGTON, Mass. — Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that, in a landmark sale for the company, it has sold 32 of its QS-B220 desktop explosives and drugs trace detectors across eight correctional facilities in Mexico. The units, […]
NEWARK, Calif. –– Morpho (Safran), through its subsidiary Morpho Detection, today announced the Canadian Air Transport Security Authority (CATSA) has ordered five CTX™ explosives detection systems (EDS) valued at $6 million. Part of a five-year standing offer announced in 2013, Morpho Detection recently delivered two compact CTX 5800™ and will supply three high-speed CTX 9800 […]
WILMINGTON, Mass. — Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has sold 178 of its QS-B220 desktop explosives trace detectors to all three major Parisian airports. Over the past few months, Implant Sciences has won a series […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
